BlackRock, Inc. 13D and 13G filings for Core Scientific, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 4:15 pm Sale | 2024-01-23 | 13D | Core Scientific, Inc. CORZQ | BlackRock Inc. BLK | 2,239,620 1.200% | -2,772,098 (-55.31%) | Filing |
| 2023-11-27 4:21 pm Purchase | 2023-11-16 | 13D | Core Scientific, Inc. CORZQ | BlackRock Inc. BLK | 5,011,718 1.300% | 273,940 (+5.78%) | Filing |
| 2023-02-09 4:30 pm Unchanged | 2023-02-09 | 13D | Core Scientific, Inc. CORZQ | BlackRock Inc. BLK | 4,737,778 1.200% | 0 (Unchanged) | Filing |
| 2022-12-30 07:00 am Sale | 2022-12-22 | 13D | Core Scientific, Inc. CORZQ | BlackRock Inc. BLK | 4,737,778 1.200% | -3,542,473 (-42.78%) | Filing |
| 2022-12-29 6:01 pm Purchase | 2022-12-21 | 13G | Core Scientific, Inc. CORZQ | BlackRock Inc. BLK | 8,280,251 2.200% | 8,280,251 (New Position) | Filing |